Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesDiverse Vasopressin V2 Receptor Functionality Underlying Partial Congenital Nephrogenic Diabetes Insipidus
American Journal of Physiology: Renal Physiology, 10/08/09
Faerch M et al. – Ligand binding and signal transduction capability is dependent on localization of the amino acid variation. Striking divergences, at the level of receptor functionality may thus underlie similar clinical phenotypes in CNDI.
Related Articles
Autosomal recessive familial neurohypophyseal diabetes insipidus - onset in early infancy
European Journal of Endocrinology, 11/10/09
Relevance Score: 67%
Vasopressin Type 2 Receptor V88M Mutation: Molecular Basis of Partial and Complete Nephrogenic Diabetes Insipidus
Nephron: Physiology, 10/08/09
Relevance Score: 65%
Study: Intervention raises costs for diabetes
Medical Economics, 10/21/09
Relevance Score: 64%
Challenges in management of patients with intracranial germ cell tumor and diabetes insipidus treated with cisplatin and/or ifosfamide based chemotherapy
Journal of Neuro-Oncology, 10/14/09
Relevance Score: 64%
Prevention of Type 2 Diabetes: Risk Status, Clinic, and Community
Journal of General Internal Medicine, 11/09/09
Relevance Score: 48%
Today in Endocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Stone composition and metabolic status
Urological Research - Urolithiasis, 11/25/09
A Trial of Darbepoetin Alfa in Type 2 Diabetes and Chronic Kidney Disease
New England Journal of Medicine, 11/20/09
Addition of Angiotensin Receptor Blockade or Mineralocorticoid Antagonism to Maximal Angiotensin-Converting Enzyme Inhibition in Diabetic Nephropathy
Journal of the American Society of Nephrology, 11/20/09
Today in Nephropathies...keeping you current
Receive free subspecialty "5-minute updates" via email
Association of the PPARGC1A Gene Polymorphism With Diabetic Nephropathy in an Asian Indian Population (CURES-41)
Metabolic Syndrome and Related Disorders, 11/25/09
Ultrastructural changes in the glomerular filtration barrier and occurrence of proteinuria in Chinese patients with type 2 diabetic nephropathy
Diabetes Research and Clinical Practice, 11/25/09
Efficacy and safety of angiotensin II receptor type 1 antagonists in children and adolescents
Pediatric Nephrology, 11/23/09
Article Search
Sponsor